ArticleHeliyon2024
A novel approach for identification of zoonotic trypanosome utilizing deep metric learning and vector database-based image retrieval system.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial intelligence-powered microscopy: Transforming the landscape of parasitology.Journal of microscopy · 2026Review
- YOLO-Tryppa: A Novel YOLO-Based Approach for Rapid and Accurate Detection of Small Trypanosoma Parasites.Journal of imaging · 2025Article
- Identification of veterinary and medically important blood parasites using contrastive loss-based self-supervised learning.Veterinary world · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trypanosomiasis, a significant health concern in South America, South Asia, and Southeast Asia, requires active surveys to effectively control the disease. To address this, we have developed a hybrid model that combines deep metric learning (DML) and image retrieval. This model is proficient at identifying Trypanosoma species in microscopic images of thin-blood film examinations. Utilizing the ResNet50 backbone neural network, a trained-model has demonstrated outstanding performance, achieving an accuracy exceeding 99.71 % and up to 96 % in recall. Acknowledging the necessity for automated tools in field scenarios, we demonstrated the potential of our model as an autonomous screening approach. This was achieved by using prevailing convolutional neural network (CNN) applications, and vector database based-images returned by the KNN algorithm. This achievement is primarily attributed to the implementation of the Triplet Margin Loss function as 98 % of precision. The robustness of the model demonstrated in five-fold cross-validation highlights the ResNet50 neural network, based on DML, as a state-of-the-art CNN model as AUC >98 %. The adoption of DML significantly improves the performance of the model, remaining unaffected by variations in the dataset and rendering it a useful tool for fieldwork studies. DML offers several advantages over conventional classification model to manage large-scale datasets with a high volume of classes, enhancing scalability. The model has the capacity to generalize to novel classes that were not encountered during training, proving particularly advantageous in scenarios where new classes may consistently emerge. It is also well suited for applications requiring precise recognition, especially in discriminating between closely related classes. Furthermore, the DML exhibits greater resilience to issues related to class imbalance, as it concentrates on learning distances or similarities, which are more tolerant to such imbalances. These contributions significantly make the effectiveness and practicality of DML model, particularly in in fieldwork research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.